Mallinckrodt Pharma Ip Trading Dac Company Profile
✉ Email this page to a colleague
Biologic Drugs for Mallinckrodt Pharma Ip Trading Dac
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 10,562,956 | 2036-10-24 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 8,821,861 | 2028-10-02 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 9,827,205 | 2029-12-12 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 10,562,956 | 2036-10-24 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 8,821,861 | 2028-10-02 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 9,827,205 | 2029-12-12 | DrugPatentWatch analysis and company disclosures |
| Mallinckrodt Pharma Ip Trading Dac | RAPLIXA | fibrin sealant (human) | Powder | 125523 | 10,562,956 | 2036-10-24 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
